SLC1A2 Gene Polymorphism Influences Methamphetamine-Induced Psychosis.

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• The SLC1A2 gene encodes the excitatory amino acid transporter 2, crucial for glutamate reuptake in the central nervous system.
• Genetic variations in glutamate transporters are implicated in drug dependence and psychiatric disorders.
• Methamphetamine (METH) dependence is a significant public health concern associated with psychosis and mania.

Purpose of the Study:

• To investigate the association between the SLC1A2 rs4755404 single nucleotide polymorphism (SNP) and methamphetamine dependence.
• To examine the relationship between the rs4755404 SNP and METH-induced psychosis and mania in a Malaysian population.

Main Methods:

• Genotyping of the rs4755404 polymorphism in 285 METH-dependent males and 251 male controls from Malaysia.
• Analysis included Malay, Chinese, Kadazan-Dusun, and Bajau ethnic groups.
• Statistical analysis of genotype and allele frequencies to determine associations.

Main Results:

• A significant association was found between the rs4755404 polymorphism and METH-induced psychosis (p=0.041) in pooled METH-dependent subjects.
• No significant association was observed between the rs4755404 polymorphism and METH dependence.
• The rs4755404 polymorphism was not significantly associated with METH-induced mania across ethnicities.

Conclusions:

• The SLC1A2 rs4755404 gene polymorphism may confer susceptibility to METH-induced psychosis.
• The GG homozygous genotype of rs4755404 might be a risk factor for developing METH-induced psychosis.
• Further research is needed to elucidate the precise role of SLC1A2 in METH-related psychiatric complications.